ADC Therapeutics Reveals Promising ZYNLONTA® Data for Marginal Zone Lymphoma at ICML 2025 #Switzerland #ADC_Therapeutics #Lausanne #ZYNLONTA® #Marginal_Zone_Lymphoma
0
0
0
0
ADC Therapeutics Reveals Promising ZYNLONTA® Data for Marginal Zone Lymphoma at ICML 2025 #Switzerland #ADC_Therapeutics #Lausanne #ZYNLONTA® #Marginal_Zone_Lymphoma